BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 14, 2008
View Archived Issues
Bentley reports positive results from phase II clinical study of Nasulin for type 2 diabetes
Read More
Clavis Pharma successfully completes Elacyt phase I clinical trial in hematology
Read More
Alocrest demonstrates preliminary efficacy and tolerability in phase I clinical trial
Read More
Primary endpoint met in second Avastin phase III study in metastatic breast cancer
Read More
Nektar restructures to become a therapeutics drug development organization
Read More
MorphoSys receives Dutch CTA approval to initiate a phase I clinical trial of MOR-103
Read More
New drugs for lipoprotein disorders reported in recent Auspex patent
Read More
Vaccinogen acquires rights to OncoVax vaccine to combat recurrence of colon cancer
Read More
Presidio and Numerate enter collaboration for novel small-molecule HCV inhibitors
Read More
Unigene initiates phase I/II clinical study of oral calcitonin for the treatment of osteoporosis
Read More
Diamyd submits answer to FDA question relating to phase III IND application for Diamyd
Read More
Dyax and sanofi-aventis enter agreements for fully human monoclonal antibody DX-2240
Read More
Schering-Plough and OraSure enter agreement for rapid point-of-care oral hepatitis C test
Read More
Horizon Therapeutics completes enrollment in two phase III clinical trials for HZT-501
Read More
Napo and Trine terminate license agreement for gastrointestinal product crofelemer
Read More
AEterna Zentaris commences dosing in phase II trial of cancer drug AEZS-108
Read More
Antares receives positive guidance from EMEA regarding registration of ATD Gel
Read More
Kamada to initiate phase II clinical trials of alpha-1 antitrypsin drug for bronchiectasis
Read More
Favorable preclinical profile of novel HIV integrase inhibitor INH-I001
Read More
Promising anti-HIV profile for novel NNRTIs developed at Ardea
Read More
Ono updates third quarter developments
Read More
Introgen and H. Lee Moffitt Cancer Center initiate phase II INGN-225 trial in small cell lung cancer
Read More
Taisho's novel CB2 receptor agonist shows analgesic activity in vivo
Read More
PF-232798 profiled at the CROI meeting
Read More
Recent Amgen patents disclose novel agents for autoimmune diseases
Read More
New treatment option for thrombotic disorders described in recent Bayer patent
Read More